fda changes semaglutide just got FDA-approved for kidney disease. This everything., January 2025. The approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Navigating Compounded Semaglutide: What Health
Description
Las protenas magras (aves, pescado, huevos, legumbres) son esenciales para preservar la masa muscular durante el tratamiento, con recomendaciones de 1.0-1.5 g/kg de peso corporal diario
The neurodegeneration program lost its two largest tests
It does not interpret results or replace clinical guidance
It's just physics and geometry
Semaglutides also have opened the door to reframing obesity as a medical condition without shame
